Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID) [PDF]
Veterinary Sciences, 2022 Poor recognition of subtle clinical abnormalities and equivocal ACTH concentrations make early diagnosis of PPID difficult. Progressive clinical findings and corresponding ACTH concentrations in horses transitioning to PPID over time have not been ...
Naomi C. Kirkwood +2 more
doaj +2 more sources
Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses [PDF]
Journal of Veterinary Internal Medicine, 2021 Background Diagnosis of pituitary pars intermedia dysfunction (PPID) is problematic because of large variations in ACTH concentrations. Hypothesis/Objectives Compare the test characteristics of baseline and post–thyrotropin‐releasing hormone (TRH ...
Remona Horn +5 more
doaj +2 more sources
Equine pituitary pars intermedia dysfunction: current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group [PDF]
Australian Veterinary Journal, 2018 The purpose of this article is to provide a review of the current knowledge and opinions about the epidemiology, clinical findings (including sequelae), diagnosis, treatment and monitoring of equine pituitary pars intermedia dysfunction, particularly in ...
Cj Secombe +2 more
exaly +2 more sources
Characterization and comparison of fecal microbiota in horses with pituitary pars intermedia dysfunction and age‐matched controls [PDF]
Journal of Veterinary Internal MedicineBackground Altered gut microbiota has been associated with dopaminergic degenerative diseases in people, but studies on horses with pituitary pars intermedia dysfunction (PPID) are lacking.
Wenqing Wang +4 more
doaj +2 more sources
Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction [PDF]
Frontiers in Veterinary ScienceIntroductionDopaminergic agonists are accepted as the most effective treatment for pituitary pars intermedia dysfunction. However, some horses are refractory to daily oral pergolide, the recommended registered treatment. Extended-release cabergoline (ERC)
Tania Sundra +4 more
doaj +2 more sources
Association Between Adrenocorticotropic Hormone Concentration and Clinical Signs of Pituitary Pars Intermedia Dysfunction in Swiss and Austrian Equids [PDF]
Journal of Veterinary Internal MedicineBackground There remains a scarcity of data concerning the relationship between the clinical signs associated with PPID and plasma ACTH concentrations. Objectives Report the frequency of clinical signs in the study cohort and identify individual clinical
Nathalie Fouché +5 more
doaj +2 more sources
Histopathological hoof laminar changes in horses with Pituitary Pars Intermedia Adenoma: cases report [PDF]
Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2015 Laminitis in horses is often associated with endocrine disorders, especially the pituitary pars intermedia dysfunction (PPID) in older animals. Morphologic exams of the laminar tissue of the hoof were performed in two horses with suspected PPID, with no ...
L. M. Laskoski +9 more
doaj +2 more sources
Journal of Zoo and Wildlife Medicine, 2009 Pituitary pars intermedia dysfunction (PPID), also known as Equine Cushing's disease, is most often diagnosed in older horses and ponies. To the authors' knowledge, there have been no reports of its diagnosis in captive nondomestic equids.
Alison J Peel, Andrew Routh
exaly +2 more sources
Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction [PDF]
AnimalsFifty-two horses aged >15 years, diagnosed with pituitary pars intermedia dysfunction (PPID), and displaying hypertrichosis were recruited via an online survey of PPID horse owners. From mid-December, group T (n = 29) wore Equilume® light masks extending
Sinead Parmantier +4 more
doaj +2 more sources
Management of pituitary pars intermedia dysfunction in practice: A clinical audit
The Veterinary Journal, 2022 In horses/ponies with pituitary pars intermedia dysfunction (PPID), pergolide mesylate treatment, with monitoring of therapeutic response, is recommended by contemporaneous literature and equine endocrinologists.
Steel, NL, Ireland, JL, McGowan, CM
core +3 more sources